Shlomo Almashanu
Research Subjects
Shlomo Almashanu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ghadir Elias-Assad
Pediatric Endocrine Institute, Ha’Emek Medical Center, Afula 1834111, Israel
1 shared publication - Leraz Tobias
Pediatric Department B, Ha’Emek Medical Center, Afula 1834111, Israel
1 shared publication - Morad Khayat
Genetic Institute, Ha’Emek Medical Center, Afula 1834111, Israel
1 shared publication - Osnat Admoni
Pediatric Endocrine Institute, Ha’Emek Medical Center, Afula 1834111, Israel
1 shared publication - Yardena Tenenbaum-Rakover
Pediatric Endocrine Institute, Ha’Emek Medical Center, Afula, Israel
1 shared publication
Latest Publications
- Open Access
- 30 August 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (17) , 3898
Long-Term Outcome of Patients with TPO Mutations
Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patients with primary CH caused by TPO deficiency were enrolled. The follow-up period was up to 43 years. Over time, 20 patients (61%) developed MNG. Eight patients (24%) underwent thyroidectomy: one of them had minimal invasive follicular thyroid carcinoma. No association was found between elevated lifetime TSH levels and the development of goiter over the years. Conclusions: This cohort represents the largest long-term follow up of patients with TPO deficiency. Our results indicate that elevated TSH alone cannot explain the high rate of goiter occurrence in patients with TPO deficiency, suggesting additional factors in goiter development. The high rate of MNG development and the risk for thyroid carcinoma indicate a need for long-term follow up with annual ultrasound scans.
- 30 August 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (17) , 3898
Open AccessLong-Term Outcome of Patients with TPO Mutations
Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patients with primary CH caused by TPO deficiency were enrolled. The follow-up period was up to 43 years. Over time, 20 patients (61%) developed MNG. Eight patients (24%) underwent thyroidectomy: one of them had minimal invasive follicular thyroid carcinoma. No association was found between elevated lifetime TSH levels and the development of goiter over the years. Conclusions: This cohort represents the largest long-term follow up of patients with TPO deficiency. Our results indicate that elevated TSH alone cannot explain the high rate of goiter occurrence in patients with TPO deficiency, suggesting additional factors in goiter development. The high rate of MNG development and the risk for thyroid carcinoma indicate a need for long-term follow up with annual ultrasound scans.